DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Synarel (Nafarelin Acetate Nasal) - Published Studies

 
 



Synarel Related Published Studies

Well-designed clinical trials related to Synarel (Nafarelin Nasal)

A randomized, parallel, comparative study of the efficacy and safety of nafarelin versus danazol in the treatment of endometriosis in Taiwan. [2005.07]

Well-designed clinical trials possibly related to Synarel (Nafarelin Nasal)

A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count. [2010.06]

Recrudescence of spermatogenesis in the dog following downregulation using a slow release GnRH agonist implant. [2009.07]

Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy. [2009.04]

Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. [2008.02]

Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. [2007.11.16]

Luteal phase characteristics following GnRH antagonist or agonist treatment - a comparative study. [2006.01]

A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. [2006.01]

Other research related to Synarel (Nafarelin Nasal)

Reversible downregulation of endocrine and germinative testicular function (hormonal castration) in the dog with the GnRH-agonist azagly-nafarelin as a removable implant "Gonazon"; a preclinical trial. [2009.04.15]

Other possibly related research studies

GnRH analogs: options for endometriosis-associated pain treatment. [2006.11]

A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates. [2006.10]

Treatment with a subcutaneous GnRH agonist containing controlled release device reversibly prevents puberty in bitches. [2006.10]

Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review. [2008.09]

Successful pregnancy after gonadotropin-releasing hormone analogue and hysteroscopic myomectomy in a woman with diffuse uterine leiomyomatosis. [2009.07]

Evaluation of the clinical efficacy of Gonazon implants in the treatment of reproductive pathologies, behavioral problems, and suppression of reproductive function in the male dog. [2010.04.15]

Development and validation of a LC-MS/MS method for determination of bivalirudin in human plasma: Application to a clinical pharmacokinetic study. [2010.05.01]

Controlled delivery of a GnRH agonist by a silastic implant (Gonazon) results in long-term contraception in queens. [2009.07]

Gonadotropin releasing hormone agonists: Expanding vistas. [2011.10]

A case of progesterone-induced anaphylaxis, cyclic urticaria/angioedema, and autoimmune dermatitis. [2011.04]

Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists. [2010.09]

A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count. [2010]

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial. [2014]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017